|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/663 | (2006.01) |
| A61P 19/10 | (2006.01) |
| (11) | Number of the document | 1175904 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01201913.9 |
| Date of filing the European patent application | 1998-07-17 | |
| (97) | Date of publication of the European application | 2002-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2007-03-28 |
| (46) | Date of publication of the claims translation | 2007-05-25 |
| (30) | Number | Date | Country code |
| 53351 P | 1997-07-22 | US | |
| 53535 P | 1997-07-23 | US | |
| 9717590 | 1997-08-20 | GB | |
| 9717850 | 1997-08-22 | GB |
| (72) |
Daifotis, Anastasia G., US
Santora, Arthur C., II, US
Yates, John A., US
|
| (73) |
MERCK SHARP & DOHME CORP.,
126 East Lincoln Avenue, Rahway, New Jersey 07065,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Alendronatas, skirtas naudoti osteoporozės gydyme |
| Alendronate for use in the treatment of osteoporosis |
| Payment date | Validity (years) | Amount | |
| 2012-06-29 | 15 | 1000.00 LTL |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2011-04-12 |